Hostname: page-component-77f85d65b8-g98kq Total loading time: 0 Render date: 2026-03-27T15:20:26.702Z Has data issue: false hasContentIssue false

Crystal structure of valganciclovir hydrochloride, C14H23N6O5Cl

Published online by Cambridge University Press:  26 December 2025

Ryan L. Hodge
Affiliation:
Department of Biology, North Central College, Naperville, IL 60540, USA
James A. Kaduk*
Affiliation:
Department of Chemistry, Illinois Institute of Technology, Chicago, IL, USA Department of Physics, North Central College, Naperville, IL, USA
Amy M. Gindhart
Affiliation:
Database, International Centre for Diffraction Data (ICDD), Newtown Square, PA, USA
Anja Dosen
Affiliation:
International Centre for Diffraction Data (ICDD), Newtown Square, PA 19073-3273, USA
Tom Blanton
Affiliation:
International Centre for Diffraction Data (ICDD), Newtown Square, PA 19073-3273, USA
*
Corresponding author: James Kaduk; Email: kaduk@polycrystallography.com

Abstract

The crystal structure of valganciclovir hydrochloride has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional theory techniques. Valganciclovir hydrochloride crystallizes in space group P212121 (#19) with a = 7.07758(23), b = 11.34599(27), c = 49.3041(22) Å, V = 3,959.22(22) Å3, and Z = 8. Solution and refinement of the structure were made difficult by the limited data range, the relatively large size of the structure, the broad diffraction peaks, the relatively low crystallinity, and the significant preferred orientation. The two independent cations are protonated at the N atoms of the valine side chains. The crystal structure is dominated by alternating layers of ring systems and protonated side chains/anions along the c-axis. In addition to the ammonium–Cl hydrogen bonds, the ring systems and side chains are linked into a three-dimensional network by hydrogen bonds. The two independent cations have very different conformations. N–H···Cl, N–H···O, O–H···N, O–H···O, and O–H···Cl, as well as C–H···Cl, C–H···N, and C–H···O hydrogen bonds, are prominent in the structure. The powder pattern is included in the Powder Diffraction File (PDF®) as entry 00-071-1641.

Information

Type
New Diffraction Data
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of International Centre for Diffraction Data
Figure 0

Figure 1. The molecular structure of valganciclovir hydrochloride.

Figure 1

Figure 2. Comparison of the powder pattern of crystalline valganciclovir hydrochloride from U.S. Patent Application 2007/0129385 (black) (Sharma et al., 2007; Ranbaxy) and Forms A (green) and B (red) from Chinese Patent CN103012404A (Jin et al., 2013). The published patterns (measured using Cu Kα radiation) were digitized using UN-SCAN-IT (Silk Scientific, 2013) and plotted using MDI JADE Pro (MDI, 2025).

Figure 2

Figure 3. The Rietveld plot for the refinement of valganciclovir hydrochloride. The blue crosses represent the observed data points, and the green line is the calculated pattern. The cyan curve is the normalized error plot. The row of red tick marks indicates the peak positions of valganciclovir hydrochloride, and the blue tick marks indicate the NaCl peak positions. The vertical scale has been multiplied by a factor of 5× for 2θ > 1.5̊, and by a factor of 20× for 2θ > 8.7̊.

Figure 3

Figure 4. Comparison of the synchrotron pattern (black) of valganciclovir hydrochloride to the pattern reported by Sharma et al. (2007) (red) and Form A reported by Jin et al. (2013) (green). The published patterns were digitized using UN-SCAN-IT (Silk Scientific, 2013) and scaled to the synchrotron wavelength of 0.413891 Å using MDI JADE Pro (MDI, 2019).

Figure 4

Figure 5. Comparison of the CRYSTAL23-optimized structure of valganciclovir hydrochloride (colored by atom type) to the VASP-optimized structure (green). The comparison was generated by the Mercury CSD-Materials/Search/Crystal Packing Similarity tool; the root-mean-square displacement is 0.895 Å. Image generated using Mercury (Macrae et al., 2020).

Figure 5

Figure 6. Comparison of the Rietveld-refined (red) and VASP-optimized (blue) structures of cation 1 of valganciclovir hydrochloride. The root-mean-square Cartesian displacement is 0.664 Å.

Figure 6

Figure 7. Comparison of the Rietveld-refined (red) and VASP-optimized (blue) structures of cation 2 of valganciclovir hydrochloride. The root-mean-square Cartesian displacement is 0.668 Å.

Figure 7

Figure 8. The asymmetric unit of valganciclovir hydrochloride, with the atom numbering. The atoms are represented by 50% probability spheroids.

Figure 8

Figure 9. The crystal structure of valganciclovir hydrochloride, viewed down the b-axis. Image generated using Diamond (Crystal Impact, 2023).

Figure 9

Figure 10. Comparison of the two cations in valganciclovir hydrochloride. Cation 1 is in green, and cation 2 is in orange.

Figure 10

Figure 11. Comparison of the observed (green) and DFT-optimized local minimum (orange) conformations of cation 1 in valganciclovir hydrochloride.

Figure 11

Figure 12. Comparison of the observed (green) and DFT-optimized local minimum (orange) conformations of cation 2 in valganciclovir hydrochloride.

Figure 12

TABLE I. Hydrogen bonds (CRYSTAL23) in valganciclovir hydrochloride.

Figure 13

Figure 13. The Hirshfeld surface of valganciclovir hydrochloride. Intermolecular contacts longer than the sum of the van der Waals radii are colored blue, and contacts shorter than the sum of the radii are colored red. Contacts equal to the sum of the radii are white.

Supplementary material: File

Hodge et al. supplementary material

Hodge et al. supplementary material
Download Hodge et al. supplementary material(File)
File 494.1 KB